Bentham Science Logo

Current Pharmaceutical Design

Volume 25, 46 Issues, 2019
ISSN: 1873-4286 (Online)
ISSN: 1381-6128 (Print)
This journal supports open access


Current Pharmaceutical Design, Volume 18 - Number 25

Neurovascular Matrix Metalloproteinases and the Blood-Brain Barrier

, 18(25): 3645 - 3648

Ji Hae Seo, Shuzhen Guo, Josephine Lok, Deepti Navaratna, Michael J. Whalen, Kyu-Won Kim and Eng H. Lo

DOI: 10.2174/138161212802002742

Cerebral Aneurysm as an Exacerbating Factor in Stroke Pathology and a Therapeutic Target for Neuroprotection

, 18(25): 3663 - 3669

Naoki Tajiri, Tsz Lau, Loren E. Glover, Kazutaka Shinozuka, Yuji Kaneko, Harry van Loveren and Cesar V. Borlongan

DOI: 10.2174/138161212802002724

Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke

, 18(25): 3704 - 3720

Xiaoming Hu, Meijuan Zhang, Rehana K Leak, Yu Gan, Peiying Li, Yanqin Gao and Jun Chen

DOI: 10.2174/138161212802002715

Cell Therapy for Stroke: Emphasis on Optimizing Safety and Efficacy Profile of Endothelial Progenitor Cells

, 18(25): 3731 - 3734

Yuji Kaneko, Naoki Tajiri, Kazutaka Shinozuka, Loren E. Glover, Nathan L. Weinbren, Lourdes Cortes and Cesar V. Borlongan

DOI: 10.2174/138161212802002733

Multiple VEGF Family Members are Simultaneously Expressed in Ovarian Cancer: a Proposed Model for Bevacizumab Resistance

, 18(25): 3784 - 3792

Arne R.M. van der Bilt, Ate G.J. van der Zee, Elisabeth G.E. de Vries, Steven de Jong, Hetty Timmer- Bosscha, Klaske A. ten Hoor, Wilfred F.A. den Dunnen, Harry Hollema and Anna K.L. Reyners

DOI: 10.2174/138161212802002661

Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

, 18(25): 3793 - 3803

Stefaan Mulier, Jean-Pierre Claes, Vincent Dierieck, Jean-Olivier Amiel, Jean-Philippe Pahaut, Luc Marcelis, Fabienne Bastin, Denis Vanderbeeken, Claude Finet, Sophie Cran and Thierry Velu

DOI: 10.2174/138161212802002616

Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

, 18(25): 3816 - 3827

Eveline M. Dijkgraaf, Marij J.P. Welters, Johan W.R. Nortier, Sjoerd H. van der Burg and Judith R. Kroep

DOI: 10.2174/138161212802002797

Related Journals

Related eBooks

eBooks Catalog